Blog

Laura Ortiz-Ravick: Increase therapeutic cancer clinical trial participation among underrepresented groups

Laura Ortiz-Ravick/LinkedIn

Jul 6, 2025, 08:12

Laura Ortiz-Ravick: Increase therapeutic cancer clinical trial participation among underrepresented groups

Laura Ortiz-Ravick, Director of National Outreach and Health Equity Partnerships at The Leukemia and Lymphoma Society, shared a post by Eric Cooks, Senior Program Director at The Leukemia & Lymphoma Society, adding:

“If you didn’t get a chance to join the live webinar on LLS’s Equity in Access Research Program, I highly recommend watching the replay!

The session offered a great overview of our current RFP focused on increasing therapeutic cancer clinical trial participation among underrepresented groups. It’s a timely and important topic—and a key part of LLS’s broader commitment to advancing equity in cancer care.

Watch the webinar.
View the RFP and application details.

If you’re working in this space or know someone who is, please help spread the word.”

Quoting Eric Cooks‘s post:

“Did you miss the pre-application webinar for LLS’s Equity in Access Research Program? Catch the replay!

We had an incredible session where LLS staff provided an overview and answered questions on our current Request for Proposals (RFP), “Building Evidence for Effective Interventions to Increase Therapeutic Cancer Clinical Trial Accrual: Promoting Access for Patients from Underrepresented Groups.” If you couldn’t join us live, now’s your chance to catch up!

Watch the full webinar here.

Whether you’re a researcher interested in applying for this funding opportunity or want to learn more about LLS’s efforts to increase clinical trial participation, this webinar is packed with valuable information.

You can find additional information, including the full RFP document, on our website.”